Month: October 2017

Q & A Member Spotlight: HeartFlow

  HeartFlow aims to fundamentally change the diagnosis and treatment of coronary artery disease. In the US alone, that puts us working to prevent and treat ~350,000 deaths per year with many, many more impacted by coronary artery disease. World-wide numbers are even more staggering. “FFRct” is HeartFlow’s FDA approved product. It is a non-invasive… Read more »